Thermo Fisher launches SARS-CoV-2 GlobalAccess Sequencing Program

By The Science Advisory Board staff writers

May 7, 2020 -- Thermo Fisher Scientific is providing 50 units of its Ion Torrent Genexus system at a subsidized price to support global COVID-19 research as part of its SARS-CoV-2 GlobalAccess Sequencing Program.

The program will be available to research consortia and industry groups battling the spread of SARS-CoV-2. This initiative follows the company's introduction of its Ion AmpliSeq SARS-CoV-2 research panel optimized for the Torrent Genexus on May 6. The company is increasing its effort to accelerate SARS-CoV-2 research by increasing access to its next-generation sequencing technology.

The GlobalAccess Sequencing Program leverages the company's experience in supporting infectious disease outbreaks and brings its newest sequencing platform to more researchers to help answer important questions associated with the pandemic, Thermo Fisher said.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here